Feedback

Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases

Affiliation
College of First Clinical Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,China
Liu, Jiahui;
Affiliation
College of First Clinical Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,China
Wei, Xiunan;
Affiliation
College of Nursing ,Shandong University of Traditional Chinese Medicine ,Jinan ,China
Wang, Tong;
Affiliation
College of First Clinical Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,China
Zhang, Miaomiao;
Affiliation
College of First Clinical Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,China
Gao, Ying;
Affiliation
Affiliated Hospital of Shandong University of Traditional Chinese Medicine ,Jinan ,China
Cheng, Yan;
Affiliation
Affiliated Hospital of Shandong University of Traditional Chinese Medicine ,Jinan ,China
Chi, Lili

Cardiovascular disease (CVD) is a serious public health problem, and among non-communicable diseases, CVD is now the leading cause of mortality and morbidity worldwide. CVD involves multiple organs throughout the body, especially the intestinal tract is the first to be involved. The impairment of the intestinal mucosal barrier is considered a significant pathological alteration in CVD and also contributes to the accelerated progression of the disease, thereby offering novel insights for CVD prevention and treatment. The treatment of Chinese medicine is characterized by multi-metabolites, multi-pathways, and multi-targets. In recent years, the studies of Traditional Chinese Medicine (TCM) in treating CVD by repairing the intestinal mucosal barrier have gradually increased, showing great therapeutic potential. This review summarizes the studies related to the treatment of CVD by TCM (metabolites of Chinese botanical drugs, TCM formulas, and Chinese patent medicine) targeting the repair of the intestinal mucosal barrier, as well as the potential mechanisms. We have observed that TCM exerts regulatory effects on the structure and metabolites of gut microbiota, enhances intestinal tight junctions, improves intestinal dyskinesia, repairs intestinal tissue morphology, and preserves the integrity of the intestinal vascular barrier through its anti-inflammatory, antioxidant, and anti-apoptotic properties. These multifaceted attributes position TCM as a pivotal modulator of inhibiting myocardial fibrosis, and hypertrophy, and promoting vascular repairment. Moreover, there exists a close association between cardiovascular risk factors such as hyperlipidemia, obesity, and diabetes mellitus with CVD. We also explore the mechanisms through which Chinese botanical drugs impact the intestinal mucosal barrier and regulate glucose and lipid metabolism. Consequently, these findings present novel insights and methodologies for treating CVD.

Graphical Abstract This review presents the progress of traditional Chinese medicines in treating CVD by repairing the intestinal mucosal barrier

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2024 Liu, Wei, Wang, Zhang, Gao, Cheng and Chi.

Use and reproduction: